HIỆU QUẢ HỖ TRỢ GIẢM CÂN CỦA BỘ SẢN PHẨM THỰC PHẨM CHỨC NĂNG ageLOC TR90 TRÊN NGƯỜI THỪA CÂN, BÉO PHÌ NGUYÊN PHÁT

Abstract

Objective: Evaluation of the efficacy support weight loss of ageLOC TR90 dietary supplement set on primary overweight and obese patients. Subjects: 60 patients diagnosed with being primary overweight and obesity in the community from January 2022December 2022. Methods: Clinical intervention study, comparing results before and after treatment. Results: After 90 days of using the product, there was a change in body indexes: average BMI decreased by 1.11 ± 0.63; average waist circumference reduced by 5.10 ± 3.25 (cm); average hip circumference decreased by 4.55 ± 3.63 (cm); the average circumference of the thigh and the average circumference of the biceps and calves decreased by statistical significance; the thickness of the skin folds below the shoulder blades decreased by 0.88 ± 0.70 (cm); the thickness of the skin folds of the ribs decreased by 1.24 ± 0.97cm (p < 0.001). Conclusion: The study results showed that the ageLOC TR90 dietary supplement has effected of supporting weight loss on primary overweight and obese patients.